A French drugs company has increased it stock to give it a 14 week buffer in the case of a hard Brexit.
The company, Sanofi, is increasing various product lines, including insulin. The concern is that if the UK can’t reach a deal with the UK there could be transportation issues by land and air.
Hugo Fry, managing director, Sanofi UK said: “The uncertainty in the Brexit negotiations means that Sanofi has been planning for a ‘no deal’ scenario.”
He continued: “Patient safety is our main priority and we have made arrangements for additional warehouse capacity in order to stockpile our products, where global supply allows, in the UK and increase UK-based resource to prepare for any changes to customs or regulatory processes.”
Mr Fry said the preparations mean that “Sanofi will hold 14 weeks stock in the UK as from April 2019, which is an increase of our current in country holding of approximately 10 weeks stock and is based on our own internal assumptions of potential delays around a ‘no deal’ scenario”.
Last month, AstraZeneca said it was increasing drug stockpiles by about 20%in preparation for a no-deal Brexit.
Jeremy Hunt warns of “economic tragedy” as prospect of a No Deal increases by the day
Since you are here
Since you are here, we wanted to ask for your help.
Journalism in Britain is under threat. The government is becoming increasingly authoritarian and our media is run by a handful of billionaires, most of whom reside overseas and all of them have strong political allegiances and financial motivations.
Our mission is to hold the powerful to account. It is vital that free media is allowed to exist to expose hypocrisy, corruption, wrongdoing and abuse of power. But we can't do it without you.
If you can afford to contribute a small donation to the site it will help us to continue our work in the best interests of the public. We only ask you to donate what you can afford, with an option to cancel your subscription at any point.
To donate or subscribe to The London Economic, click here.
The TLE shop is also now open, with all profits going to supporting our work.
The shop can be found here.
You can also SUBSCRIBE TO OUR NEWSLETTER .
